Need for ethnic-specific guidelines for prevention, diagnosis, and management of type 2 diabetes in South Asians

Diabetes Technology and Therapeutics

Volumn 17, Issue 6, 2015, Pages 435-439

  Shrivastava, Usha ^a,b   Misra, Anoop ^a,b,c  

^a National Diabetes Obesity and Cholesterol Foundation   (India)

^b Diabetes Foundation India New Delhi   (India)

^c Fortis C DOC Center for Excellence for Diabetes Metabolic Diseases and Endocrinology   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADIPONECTIN; C REACTIVE PROTEIN; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPOPROTEIN;

ABDOMINAL OBESITY; BODY MASS; CARDIOVASCULAR DISEASE; DIET; DRUG COST; ETHNICITY; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH EDUCATION; HUMAN; INDIAN; INSULIN PUMP; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT MONITORING; PHENOTYPE; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REHABILITATION CARE; REVIEW; RURAL AREA; SECONDARY HEALTH CARE; SOCIOECONOMICS; SOUTH ASIA; SOUTH ASIAN; TERTIARY HEALTH CARE; UNITED KINGDOM; URBAN AREA; WAIST CIRCUMFERENCE; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; ETHNOLOGY; NEEDS ASSESSMENT; STANDARDS;

ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; HUMANS; NEEDS ASSESSMENT; PRACTICE GUIDELINES AS TOPIC;

EID: 84929255798     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0213     Document Type: Review

References (33)

1. World Health Organization: Diabetes Fact Sheet N312. 2012. www.who.int/mediacentre/factsheets/fs312/en/index .html (accessed June 20, 2014).
2. Misra A, Khurana L: Obesity related non-communicable diseases; South Asians vs white Caucasians. Int J Obes 2011;35:167-187.
3. Misra A, Shrivastava U: Obesity and dyslipidemia in South Asians. Nutrients 2013;5:2708-2733.
4. International Diabetes Federation: IDF Diabetes Atlas, 6th ed. Brussels: International Diabetes Federation, 2013.
5. Ramachandran A, Mary S, Yamuna A, et al.: High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care 2008;31: 893-898.
6. Anjana RM, Pradeepa R, Deepa M, et al.: Prevalence of diabetes and pre-diabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research-INdiaDIABetes (ICMR-INDIAB) study. Diabetologia 2011;54:3022-3027.
7. Misra A, Ramchandran A, Jayawardena R, et al.: Diabetes in South Asians. Diabet Med 2014;31:1153-1162.
8. Satyavani K, Hemalatha K, Tharkar S, et al.: The costs of treating long term diabetic complications in a developing country: a study from India. J Assoc Physicians India 2013; 61:102-109.
9. American Diabetes Association: Standards of medical care in diabetes-2014. Diabetes Care 2014;37(Suppl 1): S14-S80.
10. Misra A: Revision of limits of body mass index to define overweight and obesity are needed for the Asian ethnic groups. Int J Obes Relat Metab Disord 2003;27:1294-1296.
11. Misra A, Chowbey PK, Makkar BM, et al.: Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India 2009;57:163-170.
12. World Health Organization: How Do We Define Obesity and Overweight? Obesity and Overweight. www.who.int/ dietphysicalactivity/media/en/gsfs-obesity.pdf (accessed June 29, 2014).
13. International Diabetes Federation: IDF Worldwide Definition of the Metabolic Syndrome. www.idf.org/metabolicsyndrome (accessed June 17, 2014).
14. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106: 3143-3421.
15. Gulati S, Misra A, Pandey RM, et al.: Effects of pistachio nuts on body composition, metabolic, inflammatory and oxidative stress parameters in Asian Indians with metabolic syndrome: a 24-wk, randomized control trial. Nutrition 2014;30:192-197.
16. Raji A, Gerhard-Herman MD, Williams JS, et al.: Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians. Diabet Med 2006;23:537-543.
17. Mu YM, Misra A, Adam JM, et al.: Managing diabetes in Asia: overcoming obstacles and the role of DPP-IV inhibitors. Diabetes Res Clin Pract 2012;95:179-188.
18. Gibbs CR, Beevers DG, Lip GYH: The management of hypertensive disease in black patients. QJM 1999;92: 187-192.
19. Numao S, Kawano H, Endo N, et al.: Short-term low carbohydrate/ high-fat diet intake increases postprandial plasma glucose and glucagon-like peptide-1 levels during an oral glucose tolerance test in healthy men. Eur J Clin Nutr 2012;66:926-932.
20. Misra A, Garg S: HbA1c and blood glucose for the diagnosis of diabetes. Lancet 2011;378:104-106.
21. Enas EA, Singh V, Munjal YP, et al.: Recommendations of the second Indo-U.S. Health Summit on prevention and control of cardiovascular disease among Asian Indians. Indian Heart J 2009;61:265-274.
22. Misra A: C-reactive protein in young individuals: problems and implications for Asian Indians. Nutrition 2004;20: 478-481.
23. Misra A, Sharma R, Gulati S, et al.: Consensus dietary guidelines for healthy living and prevention of obesity, the metabolic syndrome, diabetes, and related disorders in Asian Indians. Diabetes Technol Ther 2011;13:683-694.
24. Al-Arouj M, Assaad-Khalil S, Buse J, et al.: Recommendations for management of diabetes during Ramadan update 2010. Diabetes Care 2010;33:1895-1902.
25. Misra A, Nigam P, Hills AP, et al.: Consensus physical activity guidelines for Asian Indians. Diabetes Technol Ther 2012;14:83-98.
26. Kesavadev J, Misra A, Das AK, et al.: Suggested use of vaccines in diabetes. Indian J Endocr Metab 2012;16: 886-893.
27. Sinha K: At Rs 2, 1-Minute Diabetes Test to be Ready by Dec. October 8, 2012. www.timesofindia.com (last accessed July 7, 2014).
28. Chandie Shaw PK, Baboe F, van Es LA, et al.: South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients. Diabetes Care 2006;29:1383-1385.
29. Bhansali A, Chattopadhyay A, Dash RJ: Mortality in diabetes: a retrospective analysis from a tertiary care hospital in North India. Diabetes Res Clin Pract 2003;60:119-124.
30. Nigam P, Bhatt S, Misra A, et al.: Effect of a 6-month intervention with cooking oils containing a high concentration of monounsaturated fatty acids (olive and canola oils) in male Asian Indians with nonalcoholic fatty liver disease compared with refined oil. Diabetes Technol Ther 2013;16:255-261.
31. Indian Council of Medical Research: Guidelines for Management of Type 2 Diabetes. 2005. icmr.nic.in/guidelines-diabetes/guide-diabetes.htm (accessed June 16, 2014).
32. Khunti K, Kumar S, Brodie J: Diabetes UK and South Asian Health Foundation Recommendations on Diabetes Research Priorities for British South Asians. London: Diabetes UK, 2009.
33. Shrivastava U, Misra A: Intervention trials for prevention of metabolic syndrome and type 2 diabetes: focus on Asian Indians. Diabetes Technol Ther 2014;16:531-541.